This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Agilent Technologies To Sponsor Life Science Workshops In San Diego, San Francisco Bay Area On Dec. 11 And 12

Agilent Technologies Inc. (NYSE:A) today announced it will host two life science workshops in California this month. The first, ‘Omics Approaches in Understanding Disease, will be held in San Diego on Wednesday, Dec. 11. The San Francisco Bay Area workshop, Implementing Multi-Omics Approaches—From Discovery to Clinical Research, will be held Dec. 12. Guests will hear presentations from leading scientists using Agilent’s latest integrated biology technologies to gain new insights into drug development and disease research.

“These exciting events are designed for life scientists and clinicians involved in translational research and others interested in learning more about the power of pathway-guided multi-omics approaches to understanding the biological mechanisms of diseases,” said Leo Bonilla, Agilent’s director of Integrated Biology.

At both workshops, Dr. Robert Gerszten, director of Clinical and Translational Research at Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care, and professor of medicine at Harvard Medical School, will discuss how his team is applying multi-omics technologies to the study of cardiovascular and metabolic diseases.

Antoni Wandycz, Agilent’s director of Bioinformatics Solutions, will also present at both events. He will demonstrate how the company’s powerful GeneSpring GX statistical software tools enable rapid visualization and analysis of transcriptomics, genomics, proteomics and metabolomics data.

At the Dec. 11 workshop in San Diego, Dr. Gary Siuzdak, professor of Chemistry, Molecular and Computational Biology and senior director of Scripps Center for Metabolomics and Mass Spectrometry, will review a unique, metabolomics-based biochemical approach to understanding disease pathogenesis.

At the Dec. 12 workshop in the San Francisco Bay Area, Dr. Carlito Lebrilla, professor at UC Davis School of Medicine, will discuss how his team is developing mass-spectrometry-based tools for cancer and nutrition research.

Also at the Dec. 12 workshop, Dr. Roger Linington, associate professor of chemistry and biochemistry at UC Santa Cruz, will present his latest multi-omics research on infectious diseases, such as malaria and tuberculosis. Dr. Linington’s work focuses on natural marine products as a source of inspiration and innovation in biomedical science and drug discovery.

The Dec. 11 event will be held at Sanford Auditorium at the Sanford Consortium for Regenerative Medicine in La Jolla. The Dec. 12 event will be held at the Crown Plaza Hotel in Foster City. Customers, students and all interested guests are invited to attend both workshops and luncheons.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,098.45 +18.88 0.11%
S&P 500 2,003.37 +6.63 0.33%
NASDAQ 4,580.2710 +22.5760 0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs